Flowable Hemostats Market

Flowable Hemostats Market (Material: Porcine Gelatin and Bovine Gelatin; and Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro & Spine Surgery, Orthopedic Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Flowable Hemostats Market Outlook 2031

  • The global industry was valued at US$ 716.8 Mn in 2022
  • It is estimated to grow at a CAGR of 7.7% from 2023 to 2031 and reach US$ 1.4 Bn by the end of 2031

Analyst Viewpoint

Increase in usage of flowable hemostats in the partial splenectomy procedure is a primary factor responsible for the growth in the flowable hemostats market size. Flowable hemostats help control bleeding during the partial splenectomy procedure.

Rise in the elderly population is also fueling market progress. The geriatric population is at a greater risk of coronary heart disease, pneumonia, and osteoporosis, which need to be handled such that there is minimal blood loss during surgical treatment.

Flowable hemostats market manufacturers are offering evidence-based, data-driven optimization program based on hemostasis, which aims at curtailing intraoperative blood loss and reducing blood transfusions.

They are also entering into partnerships with hospitals in order to support these qualitative initiatives.

Market Introduction

Flowable hemostats help stop bleeding by combining mechanical tamponade effect using hemostatic materials such as gelatin and injectable clotting agents such as thrombin. Fluid hemostatic sealants are absorbable dressings that close tissue and active sources of bleeding such as lymphatics and blood vessels.

Flowable hemostats are made from biologic materials such as lyophilized fibrinogen and thrombin or synthetic materials such as cyanoacrylates. They play a vital role in limited clotting/coagulation conditions.

Liquid hemostatic agents comprise 25% aluminum chloride to arrest gingival bleeding. They play a key role in managing bleeding during dental procedures.

Designing smart hemostatic materials that are capable of mimicking natural hemostatic processes is one of the emerging trends in flowable hemostatic solutions. For instance, fibrin-structured nanofibers facilitate platelet mimicking, which promotes formation of clot and contraction of the thrombus.

However, disadvantages associated with flowable hemostats, including side-effects such as vomiting sensation, nausea, difficulty in breathing, and headache, are hampering the flowable hemostats market value to a certain extent.

Attribute Detail
Market Drivers
  • Increase in Adoption of Flowable Hemostats in Partial Splenectomy Procedure
  • Rise in Geriatric Population

Growth in Adoption of Flowable Hemostats in Partial Splenectomy Procedure

Partial splenectomy refers to the removal of 70% to 80% of splenic mass by surgery with the objective of reducing post-operative complications and preserving the splenic function.

Healthcare personnel are widely adopting flowable hemostats in the partial splenectomy procedure to control excessive bleeding during as well as post surgery.

Along these lines, thrombin-gelatin hemostatic matrix is recommended in hepatic surgeries, cardiovascular surgeries, and endoscopic sinus surgeries. Tranexamic acid-loaded starch microspheres are also likely to help with hemostatic stability.

Flowable hemostats such as Tisseel are also increasingly used during cardiopulmonary bypass, colostomy closure, splenic injury repair, and colonic anastomosis. It is the first fibrin sealant approved by the U.S. FDA.

Baxter International’s FLOSEAL Hemostatic Matrix is preferred over microporous polysaccharide powder materials. Introduction of such innovative products is propelling the flowable hemostats industry.

Rise in Geriatric Population Boosting Flowable Hemostats Market Statistics

The WHO states that 1.5 billion people worldwide would be categorized as geriatric population by 2050.

The elderly population is more prone to various chronic diseases and also takes time to recover from traumatic accidents. Therefore, it is imperative to have measures in place to control bleeding with immediate effect in such patient pool.

Flowable hemostats are applied as a part of adjunct treatment for sealing residual oozing of the tissue tracts pertaining to femoral access sites to avoid excessive bleeding. They activate the clotting mechanisms of the body.

Growth in awareness about the benefits of timely usage of flowable hemostats in the geriatric population group is driving the flowable hemostats market.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest flowable hemostats market analysis, North America constituted the largest share of the global landscape in 2022. The region is projected to maintain its dominant position during the forecast period.

High flowable hemostats market share of North America can be ascribed to the rise in number of surgeries, availability of strong healthcare infrastructure, and presence of key players in the region, especially in the U.S.

Asia Pacific is also likely to record significant market development in the near future. Healthcare facilities in the region are increasingly focusing on delivery of superlative surgical treatments.

The cases of hemophilia have risen substantially in China. As per research conducted by Haemophilia Treatment Center Collaboration Network of China (HTCCNC), more than 18,000 individuals suffer from hemophilia.

Analysis of Key Players

Companies operating in the global flowable hemostats industry are engaging in new product launches to strengthen their market position. For instance, World Monopler Enterprises and Kenyon USA are introducing their flowable hemostats to compete with the established market players.

Existing players are emphasizing on mergers & acquisitions in order to increase their market share. For instance, in July 2021, Baxter International Inc. announced that it had completed the acquisition of CryoLife, Inc.

Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated are some of the leading players summarized in the flowable hemostats market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Development

  • In January 2023, Medcura, Inc., a leading biotechnology company, announced that the U.S. FDA had granted the ‘Breakthrough Device Designation’ to its LifeGel Absorbable Surgical Hemostat LifeGel

Flowable Hemostats Market Snapshot

Attribute Detail
Market Size in 2022 US$ 716.8 Mn
Market Forecast (Value) in 2031 US$ 1.4 Bn
Growth Rate (CAGR) 7.7%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Material
    • Porcine Gelatin
    • Bovine Gelatin
  • Application
    • General Surgery
    • Cardiac Surgery
    • Vascular Surgery
    • Neuro & Spine Surgery
    • Orthopedic Surgery
    • Others
  • End-user
    • Hospitals
    • Ambulatory Surgery Centers
    • Clinics
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Johnson & Johnson
  • Baxter International, Inc.
  • Teleflex Incorporated
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global flowable hemostats market in 2022?

It was valued at US$ 716.8 Mn in 2022

How is the flowable hemostats business expected to grow during the forecast period?

It is projected to grow at a CAGR of 7.7% from 2023 to 2031

What are the key factors driving the demand for flowable hemostats?

Increase in adoption of flowable hemostats in the partial splenectomy procedure and rise in geriatric population

Which flowable hemostats end-user segment held the largest share in 2022?

The hospitals segment accounted for the largest share in 2022

Which region dominated the global flowable hemostats landscape in 2022?

North America was the dominant region in 2022

Who are the key flowable hemostats manufacturers?

Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Flowable Hemostats Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Flowable Hemostats Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Flowable Hemostats Market Analysis and Forecast, by Material

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Material, 2017–2031

            6.3.1. Porcine Gelatin

            6.3.2. Bovine Gelatin

        6.4. Market Attractiveness Analysis, by Material

    7. Global Flowable Hemostats Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. General Surgery

            7.3.2. Cardiac Surgery

            7.3.3. Vascular Surgery

            7.3.4. Neuro & Spine Surgery

            7.3.5. Orthopedic Surgery

            7.3.6. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Flowable Hemostats Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgery Centers

            8.3.3. Clinics

        8.4. Market Attractiveness Analysis, by Application

    9. Global Flowable Hemostats Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Flowable Hemostats Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Material, 2017–2031

            10.3.1. Porcine Gelatin

            10.3.2. Bovine Gelatin

        10.4. Market Value Forecast, by Application, 2017–2031

            10.4.1. General Surgery

            10.4.2. Cardiac Surgery

            10.4.3. Vascular Surgery

            10.4.4. Neuro & Spine Surgery

            10.4.5. Orthopedic Surgery

            10.4.6. Others

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Hospitals

            10.5.2. Ambulatory Surgery Centers

            10.5.3. Clinics

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Material

            10.7.2. By Application

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Flowable Hemostats Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Material, 2017–2031

            11.3.1. Porcine Gelatin

            11.3.2. Bovine Gelatin

        11.4. Market Value Forecast, by Application, 2017–2031

            11.4.1. General Surgery

            11.4.2. Cardiac Surgery

            11.4.3. Vascular Surgery

            11.4.4. Neuro & Spine Surgery

            11.4.5. Orthopedic Surgery

            11.4.6. Others

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Ambulatory Surgery Centers

            11.5.3. Clinics

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Material

            11.7.2. By Application

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Flowable Hemostats Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Material, 2017–2031

            12.3.1. Porcine Gelatin

            12.3.2. Bovine Gelatin

        12.4. Market Value Forecast, by Application, 2017–2031

            12.4.1. General Surgery

            12.4.2. Cardiac Surgery

            12.4.3. Vascular Surgery

            12.4.4. Neuro & Spine Surgery

            12.4.5. Orthopedic Surgery

            12.4.6. Others

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Ambulatory Surgery Centers

            12.5.3. Clinics

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Material

            12.7.2. By Application

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Flowable Hemostats Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Material, 2017–2031

            13.3.1. Porcine Gelatin

            13.3.2. Bovine Gelatin

        13.4. Market Value Forecast, by Application, 2017–2031

            13.4.1. General Surgery

            13.4.2. Cardiac Surgery

            13.4.3. Vascular Surgery

            13.4.4. Neuro & Spine Surgery

            13.4.5. Orthopedic Surgery

            13.4.6. Others

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Ambulatory Surgery Centers

            13.5.3. Clinics

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Material

            13.7.2. By Application

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Flowable Hemostats Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Material, 2017–2031

            14.3.1. Porcine Gelatin

            14.3.2. Bovine Gelatin

        14.4. Market Value Forecast, by Application, 2017–2031

            14.4.1. General Surgery

            14.4.2. Cardiac Surgery

            14.4.3. Vascular Surgery

            14.4.4. Neuro & Spine Surgery

            14.4.5. Orthopedic Surgery

            14.4.6. Others

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Ambulatory Surgery Centers

            14.5.3. Clinics

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Material

            14.7.2. By Application

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Johnson & Johnson

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Baxter International, Inc.

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Teleflex Incorporated

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

    List of Tables

    Table 01: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 02: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 07: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 11: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 15: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 19: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031

    Table 23: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Flowable Hemostats Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Flowable Hemostats Market Revenue (US$ Mn), by Material, 2022

    Figure 03: Global Flowable Hemostats Market Value Share, by Material, 2022

    Figure 04: Global Flowable Hemostats Market Revenue (US$ Mn), by Application, 2022

    Figure 05: Global Flowable Hemostats Market Value Share, by Application, 2022

    Figure 06: Global Flowable Hemostats Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Flowable Hemostats Market Value Share, by End-user, 2022

    Figure 08: Global Flowable Hemostats Market Value Share, by Region, 2022

    Figure 09: Global Flowable Hemostats Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 11: Global Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 12: Global Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 13: Global Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 14: Global Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 15: Global Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 16: Global Flowable Hemostats Market Value Share Analysis, by Region, 2022–2031

    Figure 17: Global Flowable Hemostats Market Attractiveness Analysis, by Region, 2023–2031

    Figure 18: North America Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Flowable Hemostats Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Flowable Hemostats Market Value Share Analysis, by Country, 2022–2031

    Figure 21: North America Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 22: North America Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 23: North America Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 24: North America Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 25: North America Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 26: North America Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 30: Europe Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 31: Europe Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 32: Europe Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 33: Europe Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 34: Europe Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 35: Europe Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 39: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 40: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 41: Asia Pacific Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 42: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 43: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 44: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Latin America Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 49: Latin America Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 50: Latin America Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 51: Latin America Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 52: Latin America Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 53: Latin America Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 57: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031

    Figure 58: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031

    Figure 59: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031

    Figure 60: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031

    Figure 61: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031

    Figure 62: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved